Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 3.230
+0.040 (1.25%)
Jun 18, 2026, 1:00 PM HKT
HKG:2563 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -131.44 | -143.78 | -189.64 | -160.51 | -278.14 |
Depreciation & Amortization | 10.62 | 9.81 | 10.56 | 10.46 | 8.65 |
Other Amortization | - | - | 0.06 | 0.04 | 0.03 |
Asset Writedown & Restructuring Costs | 2.41 | -0.2 | - | - | 0.08 |
Loss (Gain) From Sale of Investments | -11.87 | -16.3 | -9.1 | -10.85 | -22.39 |
Stock-Based Compensation | - | - | 44.4 | 80.74 | - |
Provision & Write-off of Bad Debts | 20.65 | 0.29 | -1.28 | 1.21 | 0.38 |
Other Operating Activities | 9.94 | -6.01 | -16.96 | -22.38 | 245.59 |
Change in Accounts Receivable | -15.72 | -13.33 | 25.22 | -6.9 | -20.92 |
Change in Inventory | -14.07 | -3.31 | 3.07 | -8.44 | -16.99 |
Change in Accounts Payable | -30.88 | 51.74 | 3.39 | 28.23 | 6.24 |
Change in Unearned Revenue | - | - | -0.71 | -1.53 | -1.3 |
Change in Other Net Operating Assets | 8.83 | 8.51 | -19.79 | 10.5 | - |
Operating Cash Flow | -151.52 | -112.59 | -150.78 | -79.44 | -78.77 |
Capital Expenditures | -5.42 | -40.8 | -27.84 | -31.86 | -11.06 |
Sale (Purchase) of Intangibles | - | - | - | -0.82 | - |
Investment in Securities | 83.84 | 78.6 | 145.98 | -114.11 | 121.93 |
Other Investing Activities | 11.1 | 15.68 | 13.14 | - | 17.57 |
Investing Cash Flow | 89.52 | 53.47 | 131.28 | -146.79 | 128.44 |
Short-Term Debt Issued | - | - | - | 0.07 | - |
Total Debt Issued | - | - | - | 0.07 | - |
Short-Term Debt Repaid | - | - | -0.07 | - | - |
Long-Term Debt Repaid | - | - | -1.01 | -1.13 | -1.08 |
Total Debt Repaid | - | - | -1.07 | -1.13 | -1.08 |
Net Debt Issued (Repaid) | - | - | -1.07 | -1.06 | -1.08 |
Issuance of Common Stock | - | 209.71 | - | - | 0.27 |
Other Financing Activities | -1.25 | -1.6 | -0.06 | 4.59 | - |
Financing Cash Flow | -1.25 | 208.11 | -1.13 | 3.53 | -0.81 |
Foreign Exchange Rate Adjustments | -5.27 | 2.64 | -1.39 | 14.38 | -4.9 |
Net Cash Flow | -68.52 | 151.63 | -22.02 | -208.31 | 43.96 |
Free Cash Flow | -156.94 | -153.39 | -178.62 | -111.3 | -89.83 |
Free Cash Flow Margin | -470.38% | -213.45% | -268.05% | -339.12% | -126.41% |
Free Cash Flow Per Share | -0.43 | -0.44 | -0.51 | -0.32 | -0.26 |
Cash Interest Paid | 0.05 | 0.06 | 0.06 | 0.07 | - |
Cash Income Tax Paid | - | - | - | - | 1.08 |
Levered Free Cash Flow | -77.99 | -162.66 | -99.06 | -46.54 | 23.12 |
Unlevered Free Cash Flow | -77.96 | -162.62 | -99.03 | -46.49 | 23.16 |
Change in Working Capital | -51.83 | 43.61 | 11.18 | 21.85 | -32.97 |